Implantable cardiac defibrillators.
The implantable cardioverter defibrillator (ICD) represents an important development in the effort to reduce the incidence of sudden cardiac death (almost 400,000 yearly in the United States). Early generation ICDs, which required epicardial lead systems and abdominal placement of the pulse generator, have been replaced by transvenous leads and pectoral implants. Other important refinements, which include biphasic waveforms, extensive memory capability, antitachycardia pacing, and enhanced sensing algorithms, have greatly improved patient tolerance. Ongoing trials and those in the planning stages will continue to expand the indications for ICDs and will focus on cost-effectiveness.
Peters
R W
RW
Department of Medicine, Division of Cardiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Gold
M R
MR
D001145:Arrhythmias, Cardiac / Q000503:physiopathology / Q000628:therapy*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control; D017147:Defibrillators, Implantable / Q000592:standards / Q000639:trends; D004554:Electric Countershock / Q000379:methods; D006339:Heart Rate; D006801:Humans; D011379:Prognosis